TrialEBioMedicine2025

Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial.

Nina Hertoghs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.